How is the commercialization process structured at an Alfred E. Mann Institute?
The commercialization process at an AMI incorporates three key components, with the direct mission being to expedite commercialization of university intellectual property via processes that increase the probability for success. A quantitative model that incorporates up to twelve business drivers is used to select appropriate biomedical projects that have the greatest potential to deliver the desired return on investment and benefit the patient. Human and fiscal resources are prioritized, expediting selected projects through development using proven, experienced product development staff with appropriate industry experience.
